By Dani Kass ( November 3, 2015, 3:13 PM EST) -- Mylan has infringed five of AstraZeneca's patents by filing an abbreviated new drug application with the U.S. Food and Drug Administration to make a generic version of AstraZeneca's blood thinner Brilinta, according to a suit filed Monday in West Virginia federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.